Noah S Kalman, MD

Minesh Mehta, M.D., is a renowned expert in radiation oncology, proton therapy and cancer research and serves as deputy director and the John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute, chief of Radiation Oncology at Baptist Health, and chair of the Department of Oncological Sciences at Florida International University Herbert Wertheim College of Medicine. Dr. Mehta received his medical degree with highest honors from the University of Zambia School of Medicine. He completed a residency at the University of Wisconsin, where he was later appointed chairman of the medical school’s Department of Human Oncology. As part of his leadership efforts, Dr. Mehta directed research studies, technology development and the expansion at the University of Wisconsin Cancer Center. He also directed its brain tumor program for more than 15 years, leading to his national leadership role in clinical trial research. Dr. Mehta has designed and led numerous national and international clinical studies, receiving National Institutes of Health and National Cancer Institute grants and winning honors for his research in brain and central nervous system tumors. He helped launch and was the medical director of the Maryland Proton Treatment Center in Baltimore, prior to joining Baptist Health. Dr. Mehta is board certified in radiation oncology by the American Board of Radiology and in neuro-oncology by the United Council for Neurologic Subspecialties. He has held national leadership positions in numerous organizations, including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology and the Society of Neuro-Oncology. An avid researcher, Dr. Mehta provides a multidisciplinary, innovative approach to individual care and helps all his patients understand their diagnosis, available treatment options and potential clinical trials

Marcio Fagundes, M.D., is a Board-certified radiation oncologist with Miami Cancer Institute, a part of Baptist Health South Florida. He has extensive experience in proton therapy - the most advanced cancer treatment in the world – and has conducted significant research. Dr. Fagundes has presented research results showing the advantages of proton therapy for prostate cancer, breast cancer and head and neck cancer at numerous meetings of the Particle Therapy Co-Operative Group and the American Society of Therapeutic Radiation Oncologists – two professional associations to which he belongs. He also has published dozens of articles in peer reviewed journals, including Journal of Clinical Oncology, International Journal of Particle Therapy and International Journal of Radiation Oncology. Dr. Fagundes received his medical degree from Universidade Federal do Rio Grande do Sul in Porto Alegre, Brazil, and completed a radiation oncology residency at the University of Miami Miller School of Medicine/Jackson Memorial Hospital – Sylvester Comprehensive Cancer Center. He also completed a fellowship in radiation oncology at Harvard Medical School, Massachusetts General Hospital, in Boston. He gained teaching experience as an assistant professor of radiation oncology at Tufts University School of Medicine in Boston, and currently trains his peers on an innovative treatment protocol for prostate cancer. Before joining Miami Cancer Institute, Dr. Fagundes was medical director of the Provision Center for Proton Therapy in Knoxville, Tennessee.

Robert Press, M.D., is a board-certified radiation oncologist at Baptist Health, specializing in treating central nervous system tumors and thoracic malignancies.Before joining Baptist Health in 2023, Dr. Press was a radiation oncologist at New York Proton Center, serving as the disease site lead for both central nervous system tumors and head and neck cancers. During this time, he also served as assistant clinical professor at Mt. Sinai Hospital and as a visiting investigator for the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York City.After earning his medical degree at Emory University School of Medicine, Dr. Press completed his radiation oncology residency at Winship Cancer Institute of Emory University, where he also served as chief resident. During his residency, he was named the Andrew W. Pippas Resident in Radiation Oncology, an honor selected by the faculty for a resident who exemplifies professional and compassionate patient care.Dr. Press has extensive experience using proton therapy and other advanced radiation techniques to treat challenging tumors, including re-treatment of patients who previously received radiation therapy. He has developed numerous clinical trials and published more than 60 scientific publications.Dr. Press considers it a privilege to help people through the most challenging times of their lives. He is grateful to be able to meet people in these moments and care for them with compassion, humility and grace.In his free time, Dr. Press enjoys traveling and staying active, including hiking, running, sailing and spending time with family and friends.